Our previous work highlighted the potential of tear-based microRNA (miRNA) biomarkers in AD pathogenesis by analyzing brain, eye, and tear samples from a transgenic AD (APP-PS1) mouse model at two different ages (Wijesinghe et al., 2023b). Here, APP is linked to Alzheimer disease.